|
Welcome back Rounds Table Listeners!
We are back with an oldie but a goodie!
In this repeat episode, Drs. Mike and John Fralick do a Rapid Fire session to discuss two papers exploring heart failure – specifically, if intravenous iron or the initiation of SGLT2 inhibitors in hospital for patients with heart failure improves clinical outcomes. Two papers, here we go!
-
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (0:00 – 7:18).
-
The SLGT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (7:18 – 16:31).
And for the Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
The post Episode 38 – IV Iron and SGLT2 Inhibitors in Heart Failure (Repeat) appeared first on Healthy Debate. |